Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities 1 / 7 Announcement Summary Entity name CLARITY PHARMACEUTICALS LTD Date of this announcement Wednesday...
Notification regarding unquoted securities - CU6
Filed with ASX ·
6ix hasn’t read this filing yet.
Clarity Pharmaceuticals Ltd. on 6ix
In the deck
Earlier from Clarity Pharmaceuticals
- SECuRE update
- Ceasing to be a substantial holder
- Quarterly Activities/Appendix 4C Cash Flow Report
- Becoming a substantial holder
- Data on SAR-bisPSMA to be presented at EANM
Later from Clarity Pharmaceuticals
- Clarity Pharmaceuticals Announces SECuRE Trial Update on 8 GBq 67Cu-SAR-bisPSMA dose level with two additional complete responses
- Bioshares Biotech Summit Presentation
- Preliminary Final Report
- Date of Annual General Meeting 25 November 2026
Follow Clarity Pharmaceuticals into a list and get an email when it puts out news.
Follow Clarity Pharmaceuticals